medRxiv · 2020 · 25 citations · 26 references
Life SciencesImmunologyInfectious DiseasesApoptosisCellular ImmunologyImmunology Of Infectious DiseasesApoptosis In Immune CellsCellular Immunity In InfectionImmune Cell MetabolismMitochondrial DysfunctionMyeloid-derived Suppressor CellsT Cell BiologyApoptosis In Viral InfectionCell Death In ImmunityImmune-metabolic InteractionMitochondrial Apoptosis PathwaysMitochondrial Apoptotic SignalingMonocytic Myeloid-derived Suppressor CellsSars-cov-2 InfectionVoltage-dependent Anion Channel
Abstract By interrogating metabolic programs in the peripheral blood mononuclear cells (PBMC) of acutely infected COVID-19 patients, we identified novel and distinct immune cell subsets Our studies identified a non-clonal population of T cells expressing high H3K27me3 and voltage-dependent anion channel (VDAC) with mitochondrial dysfunction and increased susceptibility to cell death. Characterized by dysmorphic mitochondria and increased cytoplasmic cytochrome c , apoptosis of these cells was inhibited by preventing VDAC aggregation or blocking caspase activation. Further, we observed a marked increase in Hexokinase II + polymorphonuclear-myeloid derived suppressor cells (PMN-MDSC). While PMN-MDSC were also found in the PBMC of patients with other viral infections, the Hexokinase II + PMN-MDSC were found exclusively in the acute COVID-19 patients with moderate or severe disease. Finally, we identified a population of monocytic MDSC (M-MDSC) expressing high carnitine palmitoyltransferase I (CPT1a) and VDAC, which were present in the PBMC of the acute COVID-19 patients, but not recovered COVID-19 patients and whose presence correlated with severity of disease. Overall, these unique populations of immune cells provide insight into the pathogenesis of SARS-CoV-2 infection and provide a means to predict and track disease severity as well as an opportunity to design and evaluate novel therapeutic regimens. One Sentence Summary Metabolic programs define unique immune cells among COVID-19 patients with severe diease.
26
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang, Yeming Wang, Xingwang Li et al. · The Lancet · 2020 · 51.8K citations · Full text
Clinical and immunological features of severe and moderate coronavirus disease 2019
Guang Chen, Di Wu, Wei Guo et al. · Journal of Clinical Investigation · 2020 · 5.1K citations · Full text
Longitudinal analyses reveal immunological misfiring in severe COVID-19
Carolina Lucas, Patrick Wong, Jon Klein et al. · Nature · 2020 · 2.3K citations · Full text